Douglas Fair1, Luke
Maese1,2, Yueh-Yun Chi3, Minjie
Li4, Douglas S. Hawkins5, Rajkumar
Venkatramani6, Erin Rudzinski7,
David Parham8, Lisa Teot9, David
Malkin10, Sharon E. Plon11,12, He
Li12, Aniko Sabo12, Philip J.
Lupo11*, Joshua D. Schiffman1,2*
1 Division of Hematology/Oncology, Department
of Pediatrics, University of Utah, Primary Children’s Hospital, Huntsman
Cancer Institute, Salt Lake City, Utah
2Family Cancer Assessment Clinic, Huntsman Cancer
Institute, University of Utah, Salt Lake City, Utah
3Department of Pediatrics, University of Southern
California, Los Angeles, California
4Statistics and Data Center, Children’s Oncology
Group, Gainesville, Florida
5Seattle Children’s Hospital, Fred Hutchinson Cancer
Research Center, University of Washington, Seattle, Washington
6Division of Hematology/Oncology, Department of
Pediatrics, Texas Children’s Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine, Houston, Texas
7Department of Laboratories, Seattle Children’s
Hospital, Seattle, Washington
8Department of Pathology and Laboratory Medicine,
Children’s Hospital Los Angeles and Keck School of Medicine, University
of Southern California, Los Angeles, California
9Department of Pathology, Boston Children’s Hospital,
Boston, Massachusetts
10Division of Hematology/Oncology, Department of
Pediatrics, The Hospital for Sick Children, University of Toronto,
Toronto, Ontario, Canada
11Division of Hematology/Oncology, Department of
Pediatrics, Baylor College of Medicine, Houston, Texas
12Human Genome Sequencing Center, Baylor College of
Medicine, Houston, Texas
*Authors contributed equally
Corresponding author:
Douglas Fair, MD, MS, FAAP
Associate Professor, Division of Pediatric Hematology and Oncology,
University of Utah
Primary Children’s Hospital | Huntsman Cancer Institute
100 N. Mario Capecchi Drive, Ste 4100
Salt Lake City, UT 84113
(801) 662-4700 (phone); (801) 662-4707 (Fax)
douglas.fair@hsc.utah.edu